| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.2 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |